Simultaneous determination of indapamide, perindopril and perindoprilat in human plasma or whole blood by UPLC-MS/MS and its pharmacokinetic application

Publication date: Available online 19 May 2018 Source:Journal of Pharmaceutical Analysis Author(s): Yi Tao, Sheng Wang, Lei Wang, Min Song, Taijun Hang Simple and sensitive methods were developed for the determination of indapamide, perindopril and its active metabolite perindoprilat in human plasma or whole blood by hyphenated ultra-performance liquid chromatography-mass spectrometry (UPLC-MS/MS). Indapamide-d3, perindopril-d4 and perindoprilat-d4 were used as the internal standards. The separation was performed on a Thermo BDS Hypersil C18 column (4.6mm×100mm, 2.4 μm) for indapamide and perindopril simultaneously following a protein precipitation pretreatment of the biosamples. The separation of perindoprilat was achieved independently on a phenomenex PFP column (4.6mm×150mm, 5 μm). All the analytes were quantitated with ESI positive ionization and multiple reactions monitoring mode. The assay exhibited a linear range of 1–250ng/mL for indapamide, 0.4–100ng/mL for perindopril and 0.2–20ng/mL for perindoprilat. The methods were fully validated to meet the requirements for bioassay in accuracy, precision, recovery, reproducible, stabilities and matrix effects, and successfully applied to the pharmacokinetic study of perindopril tert-butylamine/indapamide compound tablets in Chinese healthy volunteers and the comparative pharmacokinetic study between plasma and whole blood.
Source: Journal of Pharmaceutical Analysis - Category: Drugs & Pharmacology Source Type: research

Related Links:

Authors: PMID: 32493135 [PubMed - in process]
Source: Tumori - Category: Cancer & Oncology Tags: Tumori Source Type: research
Publication date: 6 June 2020Source: New Scientist, Volume 246, Issue 3285Author(s):
Source: New Scientist - Category: Science Source Type: research
Publication date: 6 June 2020Source: New Scientist, Volume 246, Issue 3285Author(s):
Source: New Scientist - Category: Science Source Type: research
Publication date: 6 June 2020Source: New Scientist, Volume 246, Issue 3285Author(s):
Source: New Scientist - Category: Science Source Type: research
Publication date: 6 June 2020Source: New Scientist, Volume 246, Issue 3285Author(s): Gilead Amit
Source: New Scientist - Category: Science Source Type: research
Publication date: 6 June 2020Source: New Scientist, Volume 246, Issue 3285Author(s):
Source: New Scientist - Category: Science Source Type: research
Publication date: 6 June 2020Source: New Scientist, Volume 246, Issue 3285Author(s):
Source: New Scientist - Category: Science Source Type: research
Publication date: 6 June 2020Source: New Scientist, Volume 246, Issue 3285Author(s): Chelsea Whyte
Source: New Scientist - Category: Science Source Type: research
Publication date: 6 June 2020Source: New Scientist, Volume 246, Issue 3285Author(s): Adam Vaughan
Source: New Scientist - Category: Science Source Type: research
Publication date: 6 June 2020Source: New Scientist, Volume 246, Issue 3285Author(s): Jim Peebles
Source: New Scientist - Category: Science Source Type: research
More News: China Health | Drugs & Pharmacology | Indapamide | Study